Report Highlights
The market for laboratory automation was worth nearly $2.6 billion in 2011 and $2.8 billion in 2012, and will grow at a 6.3% compound annual growth rate (CAGR) to reach $3.8 billion in 2017.
Report Includes
- An overview of the global market for laboratory automation technology, which has applications in a large number of scientific disciplines, including clinical diagnostics, drug discovery, food and agricultural research, and forensics.
- Analyses of global market trends, with data from 2010, 2011, and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- Identification of key manufacturers, technologies, and variety of factors influencing demand.
- A focus on the biotechnology, pharmaceutical, clinical diagnostics, and academic science industries, as demand for laboratory automation is strongest in these fields.
- Discussion of suppliers of laboratory automation in terms of market share, product types, and geography.
Report Scope
A particular focus will be placed on the biotechnology, pharmaceutical, clinical diagnostics and academic science industries, as demand for laboratory automation is strongest in these fields. Academic science is unique, as it entails both users of laboratory automation and creators of new uses for laboratory automation through the dissemination of new techniques and ideas through research. Staffing shortages throughout the clinical diagnostics industry have driven the demand for more automation to reduce staffing demands. New applications developed by both industry and academia, along with the demand for new drugs and clinical diagnostics, are noted drivers of demand in the clinical diagnostics, biotechnology and pharmaceutical industries.
Suppliers of laboratory automation will be discussed in terms of market share, product types and geography when possible. A focus will be placed on the integration of various product types into different market segments because similar technologies may be used in various market sectors, causing usage and scale to vary. Also, regulatory policy will be discussed, as decisions by the U.S. Food and Drug Administration (FDA) and other regulatory bodies can drive demand by approving new uses of technology and by creating market opportunities for companies looking to innovate and reduce laboratory operation costs. This regulatory policy can drive the market penetration of certain products and technologies, therefore driving demand.
Specifically excluded from this analysis is the demand for pharmaceuticals, diagnostics and other laboratory testing outside of the scope to which it generates demand for laboratory automation. Products used in the support of laboratory automation, specifically consumables used during laboratory automation, are excluded to the extent of market size and profitability of said products.
Analyst Credentials
Todd Graham is an experienced scientist who has worked in a variety of settings throughout the biotechnology industry for more than 10 years as a key technical resource for a variety of businesses. Among his accomplishments are coordinating the roll out of a new test for a major clinical laboratory services provider, developing pre-clinical and clinical assays in support of pharmaceuticals and medical devices, and being a key team member in developing novel technologies for molecular diagnostics.
Related Reports
Medical Automation Technologies, Products and Markets
The U.S. market for medical automation technologies was worth an estimated $13 billion in 2010. BCC expects this market to grow to $13.3 billion in 2011 and $21 billion by 2016, a compound annual growth rate (CAGR) of 9.5% over the next 5 years.
Process Analytical Technologies for Pharmaceuticals: Global Markets
The global market for process analytical technology (PAT) instrumentation was valued at nearly $195 million in 2010. This market is expected to increase by a 7.4% compound annual growth rate (CAGR) to reach an estimated $279 million in 2015.
Recent Reports
Pharmacy Automation: Technologies and Global Markets
The global market for pharmacy automation is estimated to increase from $7.8 billion in 2023 to reach $12.7 billion by 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023 through 2028.
Temperature Sensors: Global Markets
The global market for temperature sensors is expected to grow from $7.3 billion in 2023 to $9.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 4.3% from 2023 through 2028.
Analytical Laboratory Instruments Manufacturing: Global Markets
The global market for analytical laboratory instruments is estimated to increase from $60.9 billion in 2023 to reach $82.5 billion by 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 through 2028.
Autonomous Trucks: Global Markets
The global market for autonomous trucks is expected to grow from $3.3 billion in 2023 to over $6.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 16.2% during the forecast period of 2023-2028.
Biosensors and Nanosensors: Global Markets and Technologies
The global market for biosensors and nanosensors is expected to grow from $30.6 billion in 2023 to $43.5 billion by 2028, at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2028.
Top Trending Reports
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More